Organovo Holdings Inc - ONVO Net Assets per Single Share

Symbol and logo of brand Organovo Holdings, Inc. (ONVO)

Reliance on partnerships for drug testing creates certain risks, however, the trend in book value per share helps assess capital stability for Organovo Holdings, Inc. (ONVO). The value of 0.25 captures the magnitude of this parameter. Stability is ensured by the low demand elasticity for NovoGen 3D bioprinting and the implementation of software robots for processing liver fibrosis data.

ONVO Organovo Holdings Share Book Value (07/04/2022 - 04/24/2025)

Summary analytical data breakdowns for organovo.com (ONVO)

- share price and expert price forecast:
Stock Quotes Organovo Holdings Inc|ONVO - Price Target Chart
- issuer market value details:
Market Value Organovo Holdings|ONVO - Total Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share Organovo|ONVO - Net Asset Value|Market Capitalization to Book Value Ratio organovo.com|ONVO - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Organovo Holdings, Inc.|ONVO - Long-Term Debt to Capital|Short-Term Debt to Equity Organovo|ONVO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Organovo Holdings|ONVO - Company Long-Term Liabilities|Company Short-Term Debts Organovo|Quick Liquidity Indicator organovo.com
- earnings and multiples data:
ONVO - Final Profit
General company analysis:ONVO - Organovo Holdings Inc
Manufactured products of Organovo

This indicator determines the residual value of the issuer's net assets divided by the number of shares outstanding, allowing for an assessment of the business's intrinsic value. By analyzing the book value per share, an investor can see the resource capitalization of Organovo Holdings, Inc. (ONVO), whose value is supported by the exclusivity of its 3D liver tissue bioprinting technology and strong pricing power within the R&D segment.

Competitor analysis

ASND: Accounting Value per Share|MDGL: Net Assets per Single Share|Corcept Therapeutics (CORT) - Net Assets per Single Share|Net Asset Value per Share rhythmtx.com (RYTM)|Net Assets per Single Share Akero|Metsera, Inc. - Share Book Value|Book Value per Share MLTX|CRNX (Crinetics Corp) - Accounting Value of a Share|Book Value per Share NAMS (NewAmsterdam Pharma)|Book Value per Share soleno.life SLNO|FOLD - Net Assets per Single Share|Accounting Value of a Share ETNB (89bio Inc)|Agios Pharmaceuticals Inc (AGIO) - Net Assets per Single Share|Accounting Value per Share Structure Corp|MDXG (MiMedx Group, Inc.) - Book Value per Share|Book Value per Share rezolutebio.com|Accounting Value per Share LXRX (Lexicon Pharmaceuticals, Inc.)|MBX (MBX Biosciences, Inc.) - Accounting Value of a Share|Net Assets per Single Share Altimmune Corp ALT|AARD - Accounting Value per Share|Sagimet Biosciences - Book Value per Share|Net Asset Value per Share bioagelabs.com|BMEA (Biomea Fusion) - Accounting Value per Share|QNCX: Book Price of a Share|GUTS (Fractyl) - Book Value per Share|Book Value per Share vTv Therapeutics Inc|Book Value per Share ATPC|Net Assets per Single Share PLUR (pluri-biotech.com)|Net Assets per Single Share Synlogic SYBX|Lipocine Inc (LPCN) - Net Asset Value per Share|MTNB - Net Assets per Single Share|SPRB: Net Assets per Single Share|GLTO: Book Value per Share|CTCX - Net Assets per Share|Net Assets per Single Share Lumos Pharma|Radius Recycling Inc. (RDUS) - Net Assets per Share